chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Day 2 Mild headache, fatigue, nausea. Arm pain Rash on UNDER side of arm. Not sure if it's related or was there beforehand? Day 3-6 No symptoms other than a little tired Day 7-10 Major swelling of lymph in supraclavicular area. Also general swelling in that area. Fatigue, headache, scratchy throat, nausea Day 11 Felt okay most of the day but had a severe headache in the evening as well as achy body and nausea. Hit quickly and passed after an hour.
received 1st dose 2 years ago, series not completed; This case was reported by a other health professional via sales rep and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose of Shingrix 2 years ago.).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.   Additional Information: Analysis tab: GSK receipt date: 6-Jul-2022 Reporter's comment: The case was sent over on behalf of an health care professional. The reporter reported that medical assistant received 1st dose of Shingrix 2 years ago and also wanted to know if they should restart the series or if they should just get 2nd dose. The reporter reported but unclear if an adverse event had been filed. The reporter had no patient identifiers at this time.  Unknown if follow up was permissible. No additional details as this was the only information provided. The reporter consented to follow-up. Additional supportive information: Till the time of reporting, the patient did not receive the 2nd dose of Shingrix, which led to incomplete course of vaccination. The case was linked with US2022103211 reported by same reporter for different patient.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022103211:Same reporter. Patient 1
Pain down arm where vaccine administered. Patient described lump feeling, pain 8/10. 3:20 BP 109/71, P 84; 3:30 BP 112/70, P 93. 10/16/06 Patient reported swelling went down evening of 10/14 and she was not having any further problems
This is a spontaneous report from a non-contactable consumer (the patient). A patient of unspecified age, gender and ethnicity received PREVNAR 13 via an unspecified route of administration, on unknown date, at a single dose. Relevant medical history and concomitant medications were not reported. The patient experienced psoriatic arthritis joints, a finger on the shot arm started to 'tingle' and feel numb, fatigue, exhaustion, odd aches/pains progressed/aches and pains in other joints, the back, tendons/plagued him with pain, swelling again in the fingers. The patient had a wrist he broke fifty some years before this report has started to hurt/intense ache. The patient experienced pain in extremity, vaccination site pain, twitching, generalized pain, muscle cramp, joint pain, back pain, tendons pain, muscles pain, swelling of wrists on unknown date. The patients described the events as follow: The numbness progressed with time to include parts of the thumb and second finger and a year later the numbness was more or less noticeable. The exercise tended to make it more noticeable as did 'awareness' of it. Rubbing it tended to make it less so. It was impossible to sleep on the vaccination side without numbness running the length of the arm to the fingers. The patient went from being a 8-10 hour sleeper to a 14-16 hour sleeper also needing additional naps during the day beyond that. For six months that continued and then started to let up some. Fatigue still comes on rapidly and many naps during the day run from a few minutes to a couple of hours. There were times when a thirty minute walk will leave me exhausted - an hour or two nap would not be unusual. The pain vary from generalized aches to sharp pin pricks and include throbbing areas that feel like sharp punches. Also included are 'twitches' and feelings of impending foot or calf cramps. Aches and pains in other joints, the back, tendons and muscles have developed on a lesser scale. The psoriatic arthritis joints that have been inflammation and pain free for years have acted up causing swelling again in the fingers. The wrist he/she broke fifty some years before this report has started to hurt like it did with a very intense ache that comes and goes. The wrist also got fluid 'bumps' on it that come and go. The outcome of the events was unknown. No follow up attempts possible. No further information expected.
pt recv vax 29JAN98 & to report rash appt for eval on 20FEB98;T101 on 19FEB98 afeb 20FEB98 w/erythematous base w/a wheal lesion on neck, head & chest;
she experienced abdominal pain in her side.; has experienced fatigue; she also started to have shooting pain below the stomach and in the middle she experienced shooting pain; she had burning cramps on the waist line and that went away; She said it also felt cold.; she had burning cramps on the waist line and that went away; This is a spontaneous report from a non-contactable consumer (patient herself) via Medical Information Team. A female of an unspecified age received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number- UNKNOWN) via an unspecified route of administration on 18May2021 as 1st dose, single dose for COVID-19 immunization. Patient medical history and concomitant medications were not reported. Patient had the first dose of the Pfizer COVID-19 vaccine on 18May2021. On 30May2021 (Sunday), she has experienced fatigue. On 01June2021 (past Tuesday, two weeks after getting the vaccine), she experienced abdominal pain in her side. On an unspecified date in 2021, she said that she had burning cramps on the waist line and that went away but she also started to have shooting pain below the stomach and in the middle she experienced shooting pain. She said it also felt cold. She was scheduled to get the second dose of the vaccine tomorrow (06Jun2021). The outcome of the events was unknown.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Information has been received from a physician concerning a 63 year old female with high cholesterol and migraine and a history of deep vein thrombosis after an ankle fracture years ago, who on 15-MAY-2008 was vaccinated in the left upper arm SQ with a 0.65 ml dose of ZOSTAVAX (Lot # 659763/1875U). Concomitant therapy included LIPITOR, multivitamins (unspecified), aspirin and calcium (unspecified).
soreness in her arm at the injection site in the left arm; bruising at injection site; injection site that is red and hot; itching and redness at injection site; itching and redness at injection site; This is a spontaneous report from a contactable consumer (patient). A 94-year-old female patient received BNT162B2 (Lot/batch number and expiry date unknown), via an unspecified route of administration from 30Dec2020 to 30Dec2020 at SINGLE DOSE in the left arm for COVID-19 immunization. There were no medical history and concomitant medications. The patient stated that she got the Covid vaccine a week ago on Wednesday, 30Dec2020, 9 days ago, stated she did not seem to have any problems or side effects after, then she felt some soreness in her arm at the injection site in the left arm. States that last night on 07Jan2021, she woke up itching and redness at injection site and when she looked at her arm this morning, there is a really bad 2 1/2 to 3 inches at the injection site that is red and hot. Also she experienced bruising at injection site. She wants to know if this is a common thing. The outcome of the event "bruising at injection site" was recovering; for events Vaccination site pruritus and Vaccination site erythema was recovered on unknown dates; while unknown for the other events.  Information on the lot/batch number has been requested.
Pt. became dizzy, diaphoretic & fainted about 15 minutes after receiving GARDASIL vaccine. BP was 105/50. H. Revived after seconds & c/o blurred vision & vomited.
inject site 5-6" erythematous circular reaction w/t101; dec significantly w/in 24 hrs p/Ibuprofen
I had vaccination on 04/01/2022. I started to experience symptoms to include a dry cough low grade fever achiness in joints and muscles and fatigue on 03/09/2023. I tested COVID-19 Positive on 03/09/2023 and I contacted my physician's office. I was prescribed Paxlovid. I still have a lingering cough with fatigue on 03/20/2023. I tested COVID-19 Positive on 03/20/2023.
Swollen lymp node on neck on side of shot.  Rash on back, chest, and some in my hair that itches like crazy.    Steriod creme (Triamcinolone Acetonide) and Cephalexin 500MG.   Still have symptoms as of 4/13 and they don't seem to be getting better,  has actually spread some more.  Started 3/23 and it is now 4/13.
Patient complained of tingling in left arm, spreading to side of body. Lips maybe felt funny.
Information has been received from a physician concerning a female patient in her mid-sixties who on 04-APR-2007 was vaccinated with a dose of zoster vaccine live (Oak/Merck), Three to four days later, on approximately 07-APR-2007, the patient developed a rash on her arms and legs. The physician diagnosed the rash as contact dermatitis and successfully treated the rash with steroid medication. At the time of the report, the patient was recovering. A product quality complaint was not resolved. Additional information has been requested.
Heart palpitations, fluttering feeling/pounding sensation and heart rate sometimes dropping into the 50's started 2 days after 1st Pfizer dose. Symptoms have persisted every day since throughout the day, even at rest. Unable to workout at kickboxing class without worsening symptoms like I was able to prior to vaccination. Nurse practitioner (my primary care physician) was notified and ordered labs and an EKG. I had normal labs & an abnormal EKG showing mild sinus bradycardia with sinus arrhythmia and occasional PVC's. I was referred to see cardiology on  02/01/2022. On 01/30/2022, I developed mid-sternum chest pain (pressure) which lasted constant for 2 days and now comes and goes throughout the day every day. I was seen at ER on 01/30/2022 and released to home and told I would need a holter monitor & to keep follow-up appointment with cardiology. On the morning of 02/01/2022 I saw nurse  practitioner, in Cardiology. They performed another EKG and ordered a 14 day holter monitor which was put on me that same afternoon. I am currently wearing this until 02/15/2022. I am scheduled for an Echocardiogram on 02/16/2022 and scheduled to follow-up with nurse practitioner on 02/24/2022.
Information has been received from a physician concerning a 13 year old Caucasian male patient with no known medical history or allergies who on 08/08/01 at 15:30 was vaccinated in the upper left arm with a dose of pneumococcal vaccine 23 polyvalent  (lot number 637262/1068K). Concomitant therapy on 09/09/01 included tuberculin purified protein derivative (PPD Tine Test). There was no illness at the time of vaccination. Subsequently, on 08/10/01, the patient experienced an injection site reaction that was red, painful, warm to the touch, about 3.5 in X 6.5 in in size and a fever of 103 degree F to almost 104 deg. F that continued through 08/12/01.  The patient sought unspecified medical attention and the doctor recommend treatment with diphenhydramine HCL (Benadryl) cream, ice and children ibuprofen (Motrin).  FOLLOW UP information from the physician indicated that on 08/11/01, the patient presented to the office and he was a"sick trooper today and he definitely looks it and acts it". This is a reaction to the vaccine he received which happens to be pneumococcal vaccine 23 polyvalent". He was pale faced and very unhappy. Everything hurts him, especially his right arm where the vaccine was given. His chest was normal, lungs clear, HR 80 NSR and his abdomen was normal. He had a rather large erythematous, painful, warm to the hot swelling and induration measuring  4.5 inches in length and 3.5  inches  wide red-hot induration. His neuro exam was intact. The physician reported that this was " the first severe reaction to pneumococcal vaccine 23 polyvalent in many cases of having had the shot". The physician planned to keep in touch with the family. FOLLOW UP information from the physician indicated that the patient had totally recovered. It was reported that the patient's school required him to receive pneumococcal vaccine 23 polyvalent. No further information is available.
C/O sharp pain in (L) arm that went up to head approx 1/2 hr later c/o dizziness, chest pain, slight confusion - BP 150/70 - went to ER. CT scan, stress test complete - symptoms subsided.
This spontaneous report as received from a pharmacist refers to a 85 year old female patient with heart disease. The patient had no drug allergy. On 22-JUN-2013 the patient was vaccinated with ZOSTAVAX lot # J000430, exp. date 10-APR-2014, subcutaneous in the right arm. Concomitant therapies included indomethacin, hydralazine and potassium (manufacturer unknown). On 23-JUN-2013, patient experienced extremely itchy very, red rash which was 2 to 3 inches in diameter on her right arm a the injection site. At reporting time, the patient was recovering from the events. The patient did not seek medical attention. Pharmacist declined the VZVIP packet. Additional information has been requested.
Patient came into the office the morning off Friday, October 15th with her son. Both patient and her son received a flu vaccination given by MA. According to the nursing note, the shot was given to patient in the right deltoid without difficulty/reaction and the patient left without complaint. The patient also did not call in on Friday afternoon complaining of any pain.   Patient called in the morning of October 18th complaining of pain in the same shoulder she received the flu shot in, telling MA she believed it was from the vaccine she got on Friday. MA made her appointment to see APRN the next day 10/19/2021 as APRN was doing the COAT program on Monday. Patient then called the next morning, Tuesday October 19th letting us know she was seen in the ER of Medical Center the night before and canceled her appointment for that day with APRN. Patient sent a MyChart message a few hours later at 11:35 that read:  "Good morning Doctor   I am following up with your office after a flu shot visit with the nurse on Friday. I have been to the Medical Center emergency room yesterday and they confirmed that the shot was given too high on the shoulder and grazed the bursa sac. My shoulder swelled and was very tender on the top of my shoulder.  I had no range of motion and could not lift anything of weight. They gave me a shot of Toradol along with a prescription for it. Told me to keep it in the sling and ice it. He gave me a referral to an orthopedic, if it becomes necessary. I'm just following up to let you know that this happened. Everyone makes mistakes, with that said,  maybe  it would be good for you to address it with her. I will let you know if I continue to have problems and if indeed I do need to go to the orthopedist.  Thank you."  The message was forwarded to APRN who reached out to the patient - thanking her for letting her know and that some education would be reinforced. APRN then forwarded the message to me.
Dehydration; Itching all over; Upper back pain; Rash here and there; Chills; Body ache/ muscle pain; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 02-Mar-2021 and was forwarded to Moderna on 02-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of DEHYDRATION (Dehydration), PRURITUS (Itching all over), BACK PAIN (Upper back pain), RASH (Rash here and there) and CHILLS (Chills) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was reported.  Concomitant products included DENOSUMAB (PROLIA) and METOPROLOL for an unknown indication.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, the patient experienced DEHYDRATION (Dehydration), PRURITUS (Itching all over), BACK PAIN (Upper back pain), RASH (Rash here and there), CHILLS (Chills) and MYALGIA (Body ache/ muscle pain). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date for Chills, Myalgia and Upper back pain, at an unspecified dose and frequency. On 27-Feb-2021, DEHYDRATION (Dehydration), PRURITUS (Itching all over), BACK PAIN (Upper back pain), RASH (Rash here and there), CHILLS (Chills) and MYALGIA (Body ache/ muscle pain) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not reported.
This spontaneous report was received from a healthcare worker and licensed nurse practitioner refers to a patient (patient ID # 1677710) of unspecified age and gender. On 20-AUG-2013, the patient was vaccinated with a dose of improperly stored (Oka/Merck) VARIVAX (lot # J002618, exp date: 01-MAR-2015, 0.5 milliliter (ml), subcutaneous) (strength and indication not reported). The (Oka/Merck) VARIVAX had been stored at -10 C (celsius) (above recommended temperature range in product information) since July 2013. No adverse effect reported. It was unspecified if the patient sought medication attention. This is one of several reports received from the same source. Additional information has been requested.
Gave a BOOSTRIX vaccine IV instead of IM; Dose was given in the right antecubital; This case was reported by a pharmacist via sales rep and described the occurrence of intramuscular formulation administered by other route in a 69-year-old male patient who received DTPa (Reduced antigen) (Boostrix) (batch number 3A745, expiry date 12th March 2024) for prophylaxis.   On 17th April 2022, the patient received Boostrix (intravenous). On 17th April 2022, unknown after receiving Boostrix, the patient experienced intramuscular formulation administered by other route and vaccine administered at inappropriate site. On an unknown date, the outcome of the intramuscular formulation administered by other route and vaccine administered at inappropriate site were unknown.   Additional Information: GSK Receipt Date: 17-Apr-2022 and 18-APR-2022 Reporter's comments: This case was identified as duplicate of US2022066299. The case US2022066299 was deleted and all future correspondence would be added in the present case which stands as case of record for this patient. The duplicate case received included additional following information: Pharmacist reported that the nurse administered a dose of Boostrix to the patient in the Emergency Department, but the dose was given intravenously instead of intramuscularly. The dose was given in the right antecubital. He already spoke to Poison Control, who did not issue any immediate safety concerns. The reporter gave consent to follow up. Additional Supportive Information: The patient received Boostrix via intravenous route in right antecubital which led to, intramuscular formulation administered by other route and vaccine administered at inappropriate site.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022066299:Same reporter. FU1 deleted.
She experienced a noxious smell (ammonia) in the right nostril on the evening of her 1st COVID vaccine on 1/5/2020. It was so strong she could hardly breathe. Associated symptoms included nausea and watering of the right eye.
arm soreness Narrative: employee states: originally no issues but then later experienced that evening pain/soreness in the left arm in the area of injection
While sitting in observing unit, he feels his breathing got heavier and feels room get hot. Denies chest pain or other signs/symptoms. History of Asthma. Encouraged to use his inhaler and take some deep breath. Improvement.
Raised oval shape 40 mm x 30 mm red w/white outlining on Lt arm at site of injection. Warm to the touch, feels like bruise per pt. No fever, SOB or swelling of throat. Slight induration.
Migraine; RIGHT EYE HURTING LIKE SOMEONE HIM WITH PEPPER SPRAY; VOMITING; This spontaneous case was reported by a consumer and describes the occurrence of MIGRAINE (Migraine), EYE PAIN (RIGHT EYE HURTING LIKE SOMEONE HIM WITH PEPPER SPRAY) and VOMITING (VOMITING) in an 18-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MIGRAINE (Migraine), EYE PAIN (RIGHT EYE HURTING LIKE SOMEONE HIM WITH PEPPER SPRAY) and VOMITING (VOMITING). At the time of the report, MIGRAINE (Migraine), EYE PAIN (RIGHT EYE HURTING LIKE SOMEONE HIM WITH PEPPER SPRAY) and VOMITING (VOMITING) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: increased (High) increased.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications are provided.  No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 21-Jun-2021: TCR received on 21-Jun-2021 and contains no new information
Initial report received on 20 Jan 2011: This patient (centre number 0.5, patient number 050065) enrolled in study. Controlled study to evaluate the effect of Novartis Vaccine's Meningococcal B recombinant and MENVEO on pharyngeal carriage of N. meningitis in young adults. Study vaccination was commenced on 09 Nov 2010 at 18:11. The patient received the second dose on 07 Dec 2010 at 18:37. On 11 Dec 2010, the patient experienced severe abdominal pain. The patient was admitted to hospital and a scan done on 14 Dec 2010 confirmed appendicitis. An appendectomy was performed the same day. No treatment was prescribed until a week after when the patient had an infected scar. The patient received amoxicillin for one week. The patient had completely recovered from appendicitis. In the absence of the investigator causality, Novartis has processed the case as suspected for reporting purposes. The case will be further reassessed upon receipt of follow-up information. The investigator did indicate the event was related to the conduct of the trial.
This initial spontaneous case, was received from other health professional (nurse) on 31-Oct-2017, concerning a 54 year-old male patient. The patient had no any medical history or concomitant medications. On 31-Oct-2017, the patient was administered FLUVIRIN Thiomersal (dose: 0.5 ml, batch number: 1721501, expiry date: 30-Jun-2018, route of administration: intramuscular and anatomical location: left deltoid), that underwent first temperature excursion, at a maximum temperature of 23-degree Celsius for 3 hours. It was reported that the patient had no adverse events. The reporter assessed the events as non-serious. Follow-up received on 12-Dec-2017: Added vaccination details (route of administration: intramuscular and anatomical location: left deltoid). It was reported that the patient had no adverse events.